MedPath

Prospective randomized controlled study for preventive effect of menatetrenone against the recurrence of hepatocellular carcinoma after hepatectomy

Not Applicable
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000001815
Lead Sponsor
Second Department of Surgery Dokkyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
84
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who take warfarin or other vitamin K analogs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath